The Adis Journals portfolio is growing

The Adis portfolio of drug focused medical journals will be expanding in 2014 with the addition of thirteen established titles, offering an even greater selection of content for readers and exciting new publishing options for researchers

The Adis portfolio of drug focused medical journals will be expanding in 2014 with the addition of thirteen established titles, offering an even greater selection of content for readers and exciting new publishing options for researchers.

The open access, Springer Healthcare Rapid Publication Journals, such as Diabetes Therapy, will be published under the Adis imprint as of January 2014, as will subscription title Advances in Therapy. Two Springer titles: the European Journal of Drug Metabolism and Pharmacokinetics and Targeted Oncology will also be added to the Adis title list.

The existing portfolio will also continue to grow, with an anticipated 15% increase in content to be published in the journals next year.

The Adis Online Journal Archive is now also available to purchase, comprising of content published between 1971 and 1996 in thirteen of the Adis journals and newsletters. The archive content is now available to access on the SpringerLink and Springer for R&D platforms alongside contemporary content.

Adis content is an invaluable resource for all involved in medical research, practice or teaching; drug regulation or reimbursement, or the pharmaceutical industry.